rs144075994
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000498286.6(MTO1):āc.1051A>Gā(p.Met351Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000473 in 1,614,186 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M351T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000498286.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTO1 | NM_012123.4 | c.1051A>G | p.Met351Val | missense_variant | 6/12 | ENST00000498286.6 | NP_036255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTO1 | ENST00000498286.6 | c.1051A>G | p.Met351Val | missense_variant | 6/12 | 1 | NM_012123.4 | ENSP00000419561 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00235 AC: 358AN: 152206Hom.: 5 Cov.: 31
GnomAD3 exomes AF: 0.000624 AC: 157AN: 251424Hom.: 2 AF XY: 0.000434 AC XY: 59AN XY: 135888
GnomAD4 exome AF: 0.000275 AC: 402AN: 1461862Hom.: 3 Cov.: 31 AF XY: 0.000246 AC XY: 179AN XY: 727232
GnomAD4 genome AF: 0.00238 AC: 362AN: 152324Hom.: 5 Cov.: 31 AF XY: 0.00223 AC XY: 166AN XY: 74478
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 14, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 15, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at